Literature DB >> 26413995

MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.

Cristina Pérez-Ramírez1, Marisa Cañadas-Garre2, Miguel Ángel Molina3, María José Faus-Dáder4, Miguel Ángel Calleja-Hernández5.   

Abstract

Entities:  

Keywords:  MET; NSCLC; Pharmacogenetics; Targeted drugs

Mesh：

Substances：

Year:  2015        PMID： 26413995     DOI： 10.1016/j.phrs.2015.09.016

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  2 in total

1.  Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression.

Authors:  Nobuhiro Kanaji; Masanao Yokohira; Yuko Nakano-Narusawa; Naoki Watanabe; Katsumi Imaida; Norimitsu Kadowaki; Shuji Bandoh
Journal:  Respir Res       Date:  2017-06-15

2.  HGF/MET Regulated Epithelial-Mesenchymal Transitions And Metastasis By FOSL2 In Non-Small Cell Lung Cancer.

Authors:  Jun Yin; Weimin Hu; Wenfan Fu; Lu Dai; Zeyong Jiang; Shengpeng Zhong; Boyun Deng; Jian Zhao
Journal:  Onco Targets Ther       Date:  2019-11-05       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.